X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - NLM.NIH.GOV - DailyMed Drug Label Updates - 12/Feb 05:00

PRETOMANID tablet [Viatris Specialty LLC]

Updated Date: Wed, 12 Feb 2025 00:00:00 EST

Articles similaires

Sorry! Image not available at this time

EPIPEN (epinephrine) injection EPIPEN JR (epinephrine) injection [Viatris Specialty LLC]

nlm.nih.gov - 12/Feb 05:00

Updated Date: Wed, 12 Feb 2025 00:00:00 EST

Sorry! Image not available at this time

INSULIN GLARGINE (insulin glargine-yfgn) injection, solution [Viatris Specialty LLC]

nlm.nih.gov - 12/Feb 05:00

Updated Date: Wed, 12 Feb 2025 00:00:00 EST

Sorry! Image not available at this time

SYMFI LO (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablet, film coated [Viatris Specialty LLC]

nlm.nih.gov - 12/Feb 05:00

Updated Date: Wed, 12 Feb 2025 00:00:00 EST

Sorry! Image not available at this time

SYMFI (efavirenz, lamivudine and tenofovir disoproxil fumarate) tablet, film coated [Viatris Specialty LLC]

nlm.nih.gov - 12/Feb 05:00

Updated Date: Wed, 12 Feb 2025 00:00:00 EST

Sorry! Image not available at this time

TIZANIDINE tablet [Coupler LLC]

nlm.nih.gov - 12/Feb 05:00

Updated Date: Wed, 12 Feb 2025 00:00:00 EST

Sorry! Image not available at this time

PREDNISONE tablet [Coupler LLC]

nlm.nih.gov - 12/Feb 05:00

Updated Date: Wed, 12 Feb 2025 00:00:00 EST

Sorry! Image not available at this time

ADALIMUMAB (adalimumab-fkjp) kit [Viatris Specialty LLC]

nlm.nih.gov - 10/Feb 05:00

Updated Date: Mon, 10 Feb 2025 00:00:00 EST

Sorry! Image not available at this time

EMSAM (selegiline) patch [Viatris Specialty LLC]

nlm.nih.gov - 10/Feb 05:00

Updated Date: Mon, 10 Feb 2025 00:00:00 EST

Sorry! Image not available at this time

CELEBREX (celecoxib) capsule [Viatris Specialty LLC]

nlm.nih.gov - 10/Feb 05:00

Updated Date: Mon, 10 Feb 2025 00:00:00 EST

Sorry! Image not available at this time

TOBI PODHALER (tobramycin) capsule [Viatris Specialty LLC]

nlm.nih.gov - 13/Feb 05:00

Updated Date: Thu, 13 Feb 2025 00:00:00 EST

Les derniers communiqués